Core Viewpoint - The report from Kaiyuan Securities indicates that the insurance and brokerage sectors have shown active performance since the beginning of the year, driven by better-than-expected policy sales and a noticeable rise in the stock market, benefiting both sectors [1] Brokerage Sector - The average daily trading volume of stock funds reached 3.37 trillion yuan in the first week of 2026, up 33% month-on-month and 150% year-on-year, indicating a significant increase in market activity [2] - As of January 8, 2026, the margin trading balance reached 2.62 trillion yuan, a 44.1% increase compared to January 10, 2025 [2] - The stock market has experienced a "good start," with the Shanghai Composite Index and the Wind All A Index both surpassing new highs from 2025, which is favorable for brokerage firms and securities IT companies [2] - Regulatory policies are entering a "positive" cycle, with expected growth in investment banking, public funds, and overseas business, supporting the profitability of the securities industry in 2026 [2] - Recommended stocks include leading low-valuation brokerages such as Huatai Securities, Guotai Junan, CICC H, and CITIC Securities, as well as wealth management leaders like GF Securities and Dongfang Securities H [2] Insurance Sector - The insurance sector's performance is positively influenced by both the liability and asset sides, with the "good start" exceeding expectations [3] - The individual insurance channel is under pressure for 2025, but the "good start" for 2026 is well-prepared, with dividend insurance becoming more attractive in a bullish market [3] - The trend of residents moving deposits is expected to sustain high growth in the bancassurance channel, while health insurance is anticipated to improve under policy guidance [3] - On the asset side, stable long-term interest rates and a favorable equity market are expected to enhance net assets and profitability for insurance companies, with a gradual improvement in profit margins [3] - Recommended insurance stocks include China Pacific Insurance, Ping An Insurance, and China Life Insurance H [3]

Core Insights - The private equity market in China has started 2026 with a strong performance, highlighted by the rapid fundraising success of Shanghai Fusheng Asset, which raised 1 billion yuan in a single day for its actively managed stock private equity product, marking it as the first "daylight" private equity product of the year [1][3] - The overall performance of private equity funds in 2025 was exceptional, with an average return of 32.66% across 5022 funds, and a staggering 95.02% of these funds reported positive returns [6][8] - The trend indicates a shift in investor preference back towards subjective private equity strategies, as evidenced by the strong performance of Fusheng Asset and other leading firms, which have regained market favor after a period dominated by quantitative strategies [5][6] Fundraising and Market Dynamics - Fusheng Asset's product was sold out within seconds, reflecting a renewed interest from high-net-worth individuals in quality subjective private equity products amid a recovering equity market [1][3] - The Shanghai Composite Index has shown strong performance, reaching a ten-year high of 4121.7 points, contributing to increased market activity and investor confidence [4] - The total margin financing balance exceeded 2.62 trillion yuan, indicating heightened market liquidity and investor engagement [4] Performance Metrics - Fusheng Asset's flagship products have demonstrated remarkable returns, with the "Fusheng Positive Energy No. 2" achieving an 80.19% return in 2025, and the "Fusheng Positive Energy No. 3" yielding a cumulative return of 668.7% since its inception in 2018 [2][3] - The average return for large private equity firms (over 10 billion yuan) was 33.59%, with 98.59% of these firms reporting positive returns, showcasing their robust performance in the market [6][8] Strategy Trends - The private equity landscape is witnessing a strategic shift, with quantitative strategies previously dominating now facing competition from subjective strategies, which are regaining traction due to their strong performance [5][7] - The average return for quantitative long strategies was 45.02%, significantly outperforming subjective long strategies, which averaged 29.51% [7] - The number of large private equity firms has increased, with 113 firms now managing over 10 billion yuan, indicating a growing trend towards larger, more established players in the market [7][8]

Group 1 - The company announced the suspension of large-scale subscriptions, conversions, and regular investment for the Jianxin Hengjiu Value Mixed Securities Investment Fund starting from January 13, 2026, with a limit of 10 million yuan per account per day [1][37] - Other business operations will continue as usual during the suspension period, and the large-scale subscription and investment services will resume on January 15, 2026 [1][37] - Investors can contact the company's customer service for inquiries or visit the official website for more information [1][37] Group 2 - The Jianxin Technology Smart Selection Stock Fund is open for regular subscription, redemption, conversion, and regular investment as of January 12, 2026 [4] - The fund management company is responsible for managing and operating the fund assets, with the custodian being GuoXin Securities Co., Ltd. [4] - Investors are encouraged to check their transaction application confirmation status through sales outlets or the company's customer service [4][5]

截至2026年1月9日收盘，国信证券(002736)报收于13.45元，上涨0.6%，换手率0.38%，成交量36.06万 手，成交额4.85亿元。 当日关注点 交易信息汇总资金流向 1月9日主力资金净流入743.93万元；游资资金净流入195.38万元；散户资金净流出939.31万元。 公司公告汇总关于延长国信证券股份有限公司2026年面向专业投资者公开发行短期公司债券（第一期） 簿记建档时间的公告 国信证券股份有限公司2026年面向专业投资者公开发行短期公司债券（第一期）原定簿记建档时间为 2026年1月9日15:00至18:00。因当日市场变化较为剧烈，经全体簿记参与人协商一致，簿记建档结束时 间延长至2026年1月9日19:00。 国信证券股份有限公司2026年面向专业投资者公开发行短期公司债券（第一期）票面利率公告 国信证券股份有限公司2026年面向专业投资者公开发行短期公司债券（第一期）已获证监会注册同意， 发行规模不超过30亿元，期限为365天。2026年1月9日完成簿记询价，利率区间为1.30%-2.30%，最终确 定票面利率为1.70%。发行人将于2026年1月12日及13日面向专业机构投资 ...

Investment Rating - The industry investment rating is "Overweight" (maintained) [1] Core Views - The insurance and brokerage sectors have shown active performance at the beginning of the year, with insurance policy sales exceeding expectations and a notable rise in the stock market driving the insurance sector's growth. The brokerage sector benefits from increased market activity. The trend of "deposit migration" among residents is providing dual support for the non-bank financial sector, both in terms of liabilities (business growth) and assets (investment appreciation). The non-bank financial sector has been relatively stagnant in 2025, with valuations and institutional holdings still at low levels. Short-term funding disturbances are not a concern, and recent adjustments present good opportunities for positioning. The report remains optimistic about the non-bank sector's performance at the start of the year, with significant profit growth expected for brokerages and insurance companies in 2025, highlighting the importance of January's earnings forecasts and policy events as catalysts [5]. Summary by Sections Brokerage Sector - In the first week of 2026, the average daily trading volume of stock funds reached 3.37 trillion, a 33% increase month-on-month and a 150% increase year-on-year, indicating a significant rise in market activity. As of January 8, 2026, the margin trading balance reached 2.62 trillion, up 44.1% from January 10, 2025. The market's "opening red" has led to the Shanghai Composite Index and the Wind All A Index surpassing new highs for 2025, enhancing profitability for brokerages and securities IT companies. Regulatory policies are entering a "positive" cycle, with growth in investment banking, public funds, and overseas businesses expected to further expand, supporting the profitability of the securities industry in 2026. Current valuations and institutional holdings in the sector remain low, and the report recommends focusing on three main lines: undervalued leading brokerages such as Huatai Securities, Guotai Junan, and CICC; wealth management leaders like GF Securities and Dongfang Securities; and retail leaders benefiting from the Hainan cross-border asset management pilot, such as Guosen Securities. Beneficiary stocks include Tonghuashun [6]. Insurance Sector - The insurance sector's positive outlook is driven by both liabilities and assets. The "opening red" has catalyzed a significant rise in the insurance sector, with the individual insurance channel under pressure in 2025 but showing optimistic growth prospects for new policies in 2026 due to the transformation of dividend insurance and the integration of individual insurance reporting. The trend of deposit migration among residents is expected to sustain high growth in the bancassurance channel, while health insurance is likely to improve under policy guidance. On the asset side, stable long-term interest rates and a favorable equity market are expected to enhance net assets and profitability for insurance companies, with marginal improvements in liability costs. Over the medium to long term, the interest spread for insurance companies is expected to gradually improve, leading to a recovery in valuations. The report recommends China Pacific Insurance, Ping An Insurance, and China Life Insurance H [7]. Recommended and Beneficiary Stocks - The recommended stock portfolio includes Huatai Securities, GF Securities, Guotai Junan, CICC H, China Pacific Insurance, China Life Insurance H, Ping An Insurance, CITIC Securities, Guosen Securities, and Dongfang Securities H. Beneficiary stocks include Tonghuashun and Jiufang Zhitu Holdings [8].

Group 1 - The core viewpoint of the report is that Guosen Securities has given a "better than market" rating to Yingke Medical (300677.SZ) due to its leading position in the global disposable glove market and its diversified business layout with significant global advantages [1] - Yingke Medical's competitive edge is attributed to its multi-dimensional cost barriers and global operational capabilities, which are essential in the disposable glove industry [1] - The report highlights that the supply-demand dynamics in the disposable glove industry are continuously improving as market disruptions are clearing [1]

Group 1 - The core viewpoint of the article is that Guosen Securities has given a "better than market" rating to Aimeike (300896.SZ) based on recent developments in its product pipeline and market potential [1] - Aimeike's exclusive distribution of Huons BioPharma's injectable botulinum toxin product has received regulatory approval for sale in China, including Hong Kong and Macau, filling a gap in its product line [1] - The company is expected to enhance its core competitiveness by offering comprehensive solutions through the combination of new and existing products, with ongoing research and development in weight management and submental fat products [1] Group 2 - The medical aesthetics consumption penetration rate still has significant room for improvement, indicating potential growth opportunities for the industry [1] - Aimeike is investing in self-research to develop new product lines while also pursuing mergers and acquisitions to enrich its product pipeline and expand international business [1] - The company’s performance growth is supported by these strategies, although there are potential risks related to project progress and market competition [1]

Market Overview - The A-share market experienced a significant surge at the beginning of 2026, with the Shanghai Composite Index reaching 4120.43 points, marking a ten-year high and a record 16 consecutive days of gains [1] - The market rally is driven by a combination of global interest rate cuts and explosive growth in the commercial aerospace industry [1][3] Financial Data - Margin trading balance exceeded 2.62 trillion yuan, with a single-day increase of 24.8 billion yuan, marking the fastest influx of new capital since October 2025 [3] - The A-share market's trading volume reached 3.15 trillion yuan in the first trading week of the year, with over 3900 stocks rising [6] Commercial Aerospace Industry - The commercial aerospace sector is experiencing rapid growth, with the industry scale approaching 2.5 trillion yuan and a significant increase in satellite applications [3] - The industry has transitioned from a nurturing phase to a strategic pillar phase, as indicated by the third Commercial Aerospace Development Conference held in December 2025 [3][4] - The market value of the commercial aerospace industry surged from 376.4 billion yuan in 2015 to an estimated 2.5 trillion yuan by 2025 [4] Technological Advancements - Reusable rockets have achieved 10 launches, reducing launch costs by 35% compared to 2023 [4] - Major satellite networking plans, such as the Tianfan constellation, are advancing rapidly [4] Investment Trends - Institutional investment strategies are becoming more aggressive, with long-term capital expected to enter the market at a scale of 2 trillion yuan [6] - The establishment of the "Leading Innovation Commercial Aerospace Alliance Science and Technology Fund" with an initial scale of 2 billion yuan aims to invest in critical components and new materials [6] Sector Performance - The market is characterized by a dual focus on consumer and technology sectors, with consumer goods prices rising and expectations for strong performance during the upcoming Spring Festival [8] - The technology sector, particularly artificial intelligence and semiconductors, is benefiting from policy support and increased demand for industrial robots and software [8]

Group 1 - The report highlights that all four active quantitative strategies outperformed the equity mixed fund index this week, with absolute returns of 4.86% for the Excellent Fund Performance Enhancement Portfolio, 5.13% for the Exceeding Expectations Selected Portfolio, 5.39% for the Brokerage Golden Stock Performance Enhancement Portfolio, and 5.98% for the Growth and Stability Portfolio [1][2][17] - Year-to-date, the Excellent Fund Performance Enhancement Portfolio ranks in the 42.03 percentile among active equity funds, while the Exceeding Expectations Selected Portfolio ranks in the 38.48 percentile, the Brokerage Golden Stock Performance Enhancement Portfolio ranks in the 35.18 percentile, and the Growth and Stability Portfolio ranks in the 28.46 percentile [1][2][17] Group 2 - The Excellent Fund Performance Enhancement Portfolio is constructed by benchmarking against active equity funds rather than broad indices, utilizing quantitative methods to enhance performance based on the holdings of top-performing funds [3][18] - The Exceeding Expectations Selected Portfolio is built by screening stocks based on exceeding expectations events and analyst profit upgrades, focusing on both fundamental and technical criteria to select stocks that show strong support [4][25] - The Brokerage Golden Stock Performance Enhancement Portfolio uses a stock pool from brokerage recommendations, optimizing the combination to minimize deviation from the stock pool while aiming to outperform the equity mixed fund index [5][33] - The Growth and Stability Portfolio employs a two-dimensional evaluation system for growth stocks, prioritizing stocks closer to their earnings report dates and using multi-factor scoring to select high-quality stocks [6][40] Group 3 - The report provides performance statistics for each strategy, indicating that the Excellent Fund Performance Enhancement Portfolio achieved an annualized return of 21.40% from 2012 to 2025, outperforming the equity mixed fund index by 9.85% [55] - The Exceeding Expectations Selected Portfolio recorded an annualized return of 35.09% from 2010 to 2025, exceeding the equity mixed fund index by 23.98% [60] - The Brokerage Golden Stock Performance Enhancement Portfolio achieved an annualized return of 21.71% from 2018 to 2025, outperforming the equity mixed fund index by 14.18% [65] - The Growth and Stability Portfolio achieved an annualized return of 40.56% from 2012 to 2025, exceeding the equity mixed fund index by 26.33% [70]

Core Viewpoint - The report tracks the performance of various active quantitative strategies by GuoXin JinGong, aiming to outperform the median returns of actively managed equity funds, with a focus on four specific strategies: Excellent Fund Performance Enhancement, Unexpected Selection, Broker Golden Stock Performance Enhancement, and Steady Growth Combination [2][3]. Group 1: Performance Overview - The Excellent Fund Performance Enhancement strategy achieved an absolute return of 4.86% this week, with a relative excess return of 0.06% compared to the mixed equity fund index [3][13]. - The Unexpected Selection strategy recorded an absolute return of 5.13% this week, with a relative excess return of 0.34% [3][24]. - The Broker Golden Stock Performance Enhancement strategy had an absolute return of 5.39% this week, with a relative excess return of 0.60% [3][34]. - The Steady Growth Combination strategy achieved an absolute return of 5.98% this week, with a relative excess return of 1.19% [3][43]. - Year-to-date, the Excellent Fund Performance Enhancement strategy ranks in the 42.03 percentile among active equity funds, while the Unexpected Selection ranks in the 38.48 percentile, Broker Golden Stock in the 35.18 percentile, and Steady Growth in the 28.46 percentile [3][13][24][34][43]. Group 2: Strategy Details - The Excellent Fund Performance Enhancement strategy benchmarks against the median returns of actively managed equity funds, utilizing a quantitative approach to enhance performance based on the holdings of top-performing funds [8][49]. - The Unexpected Selection strategy focuses on selecting stocks that show both fundamental support and technical resonance, aiming to build a portfolio of stocks with unexpected performance [18][53]. - The Broker Golden Stock Performance Enhancement strategy uses a stock pool from broker recommendations, optimizing the selection to control deviations from the overall market performance [26][58]. - The Steady Growth Combination strategy employs a two-dimensional evaluation system for growth stocks, prioritizing those with upcoming earnings announcements to capture potential excess returns [35][64].